Slotnik Capital »

Apellis Pharmaceuticals shares owned by Slotnik Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Slotnik Capital from 13F filings

Historical chart of Slotnik Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Slotnik Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Slotnik Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.4M 135k 40.23

More positions owned by Slotnik Capital

Chart Industries (GTLS)
Masimo Corporation
Penumbra (PEN)
Terns Pharmaceuticals (TERN)
Liberty Broadband Corp Com Ser A (LBRDA)
Webster Financial Corporation (WBS)
Warner Bros Discovery Com Ser A (WBD)
Mission Produce (AVO)
Kenvue (KVUE)
Silicon Laboratories (SLAB)
Arcellx Common Stock (ACLX)
Aris Mng Corp (ARIS)
Liberty Broadband Corp Com Ser C (LBRDK)
Tri Pointe Homes
Western Midstream Partners L Com Unit Lp Int (WES)

View all positions for Slotnik Capital

Top funds holding Apellis Pharmaceuticals

BlackRock
venBio Select Advisor
Morgan Stanley
State Street Corporation
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
Deep Track Capital
Point72 Asset Management
Rtw Investments
HBK Investments
Suvretta Capital Management
Millennium Management
Geode Capital Management

View all funds holding Apellis Pharmaceuticals